A similar frequency of RBM10 truncating mutations was present in the MSK-IMPACT (Memorial Sloan Kettering – Integrated Mutation Profiling of Actionable Cancer Targets) EGFR-mutant LA data set (8.0%) (Supplemental Figure 1A; supplemental material available online with this article; https://doi.org/10.1172/JCI145099DS1) (30). Here, EGFR is linked to cancer.